Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

immunity · Mechanism Report

Do HHV-6 IgG levels above the lab range indicate viral reactivation?

HHV-6 IgG titers above standard lab ranges, especially when combined with lytic-phase markers, indicate a heightened immune response consistent with viral reactivation rather than remote latent exposure.

SupportedJune 19, 202610 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

HHV-6 IgG above the lab range can reflect a higher immune response to HHV-6 and, together with other lytic-phase viral markers, can fit a herpesvirus reactivation pattern rather than remote exposure alone.

laying out figure…
All 6 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states that markedly elevated HHV-6 IgG reflects an active humoral response and is not explained by past exposure alone. The mechanism graph frames this as reactivation-driven: expression of lytic proteins (e.g., dUTPase) provokes immune activation and sustained high IgG, while concurrent lytic-phase markers distinguish active replication from latency.

Verified conclusion

Human Herpesvirus 6 (HHV-6) is a ubiquitous beta-herpesvirus that establishes lifelong latency after primary infection. While standard laboratory ranges for IgG often categorize individuals as simply positive or negative, the magnitude of the antibody response and the presence of specific lytic-phase proteins provide critical insights into the virus's current biological state.

Clinical and effectiveness evidence

Elevated HHV-6 IgG titers significantly exceeding laboratory reference ranges are associated with active disease states rather than quiescent latency.

  • Disease Correlation: Research in populations with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long COVID shows that high HHV-6 IgG levels correlate with increased symptom severity, particularly fatigue and affective symptoms.
  • Predictive Value: In Multiple Sclerosis (MS), anti-HHV-6 IgG titers of ≥640 are significantly linked to higher relapse risks and faster disease progression (p < 0.05), suggesting that "high-range" IgG reflects a clinically relevant immune engagement.
  • Diagnostic Specificity: While IgG alone indicates past exposure, adding lytic-phase markers like antibodies to HHV-6 dUTPase can achieve a diagnostic accuracy of up to 91.5% in identifying active vs. latent infection.

Mechanistic explanations

The transition from latency to reactivation involves the expression of "early" lytic proteins that trigger a renewed humoral response.

  • Lytic Protein Impact: During reactivation, the virus produces enzymes such as dUTPase. This specific lytic-phase marker has been shown to induce activin-A and drive abnormal T follicular helper cell differentiation, which may explain the sustained high IgG production observed in reactivated states.
  • Viral Dynamics: Unlike latent DNA (which may persist in cells), the presence of lytic-phase markers and rising IgG titers indicates that the virus has exited its latent state and is undergoing active protein synthesis and replication.

Bottom line

HHV-6 IgG levels above the standard lab range reflect a robust immune response that, when paired with lytic-phase markers like plasma DNA or dUTPase antibodies, strongly indicates active viral reactivation rather than mere remote exposure.

References

  1. Chronic Reactivation of Persistent Human Herpesviruses EBV, HHV‐6 and VZV and Heightened Anti‐dUTPase IgG Antibodies Are a Recurrent Hallmark in Post‐Infectious ME/CFS and is Associated With Fatigue — onlinelibrary.wiley.com ↗
  2. Markers of Epstein-Barr virus and Human Herpesvirus-6 infection and multiple sclerosis clinical progression. — linkinghub.elsevier.com ↗
  3. Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis — journals.sagepub.com ↗
  4. Diagnostic assays for active infection with human herpesvirus 6 (HHV-6). — pmc.ncbi.nlm.nih.gov ↗
  5. Reactivation of Human Herpesvirus 6 and Epstein-Barr Virus in relapsing remitting multiple sclerosis: association with disabilities, disease progression, and inflammatory processes. — medrxiv.org ↗
  6. RNA Sequencing of the In Vivo Human Herpesvirus 6B Transcriptome To Identify Targets for Clinical Assays Distinguishing between Latent and Active Infections — pmc.ncbi.nlm.nih.gov ↗
  7. EBV/HHV-6A dUTPases contribute to myalgic encephalomyelitis/chronic fatigue syndrome pathophysiology by enhancing TFH cell differentiation and extrafollicular activities — insight.jci.org ↗
  8. Reactivation of herpesvirus type-6 and IgA/IgM-mediated responses to activin-A underpin Long COVID, including affective symptoms and chronic fatigue syndrome. — medrxiv.org ↗
  9. Detection of Antibodies Directed against Human Herpesvirus 6 U94/REP in Sera of Patients Affected by Multiple Sclerosis — pmc.ncbi.nlm.nih.gov ↗
  10. HHV-6 encoded small non-coding RNAs define an intermediate and early stage in viral reactivation — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible10 sourcesDoes low-normal vitamin D weaken immune resilience?→Plausible11 sourcesCan low zinc and low vitamin D constrain immune pathways while an optimal hs-CRP does not support active systemic inflammation?→